Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase

William L. Jorgensen, Juliana Ruiz-Caro, Julian Tirado-Rives, Aravind Basavapathruni, Karen S. Anderson, Andrew Hamilton

Research output: Contribution to journalArticle

Abstract

Design principles are delineated for non-nucleoside inhibitors for HIV-1 reverse transcriptase (NNRTIs). Simultaneous optimization of binding affinity for wild-type RT, tolerance for viral mutations, and physical properties is pursued. Automated lead generation with the growing program BOMB, Monte Carlo simulations with free-energy perturbation theory for lead optimization, and property analysis with QikProp are featured. An initial 30 μM lead has been optimized rapidly to the 10 nM level.

Original languageEnglish (US)
Pages (from-to)663-667
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number3
DOIs
StatePublished - Feb 1 2006

Fingerprint

Computer-Aided Design
Computer aided design
Free energy
Physical properties
Mutation
Lead
Human immunodeficiency virus 1 reverse transcriptase

Keywords

  • Anti-HIV drugs
  • Computer-aided drug design
  • NNRTI
  • Structure-based drug design

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. / Jorgensen, William L.; Ruiz-Caro, Juliana; Tirado-Rives, Julian; Basavapathruni, Aravind; Anderson, Karen S.; Hamilton, Andrew.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 16, No. 3, 01.02.2006, p. 663-667.

Research output: Contribution to journalArticle

Jorgensen, William L. ; Ruiz-Caro, Juliana ; Tirado-Rives, Julian ; Basavapathruni, Aravind ; Anderson, Karen S. ; Hamilton, Andrew. / Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. In: Bioorganic and Medicinal Chemistry Letters. 2006 ; Vol. 16, No. 3. pp. 663-667.
@article{951a7c1c9cbe46dfb3265aaf3c45d04c,
title = "Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase",
abstract = "Design principles are delineated for non-nucleoside inhibitors for HIV-1 reverse transcriptase (NNRTIs). Simultaneous optimization of binding affinity for wild-type RT, tolerance for viral mutations, and physical properties is pursued. Automated lead generation with the growing program BOMB, Monte Carlo simulations with free-energy perturbation theory for lead optimization, and property analysis with QikProp are featured. An initial 30 μM lead has been optimized rapidly to the 10 nM level.",
keywords = "Anti-HIV drugs, Computer-aided drug design, NNRTI, Structure-based drug design",
author = "Jorgensen, {William L.} and Juliana Ruiz-Caro and Julian Tirado-Rives and Aravind Basavapathruni and Anderson, {Karen S.} and Andrew Hamilton",
year = "2006",
month = "2",
day = "1",
doi = "10.1016/j.bmcl.2005.10.038",
language = "English (US)",
volume = "16",
pages = "663--667",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase

AU - Jorgensen, William L.

AU - Ruiz-Caro, Juliana

AU - Tirado-Rives, Julian

AU - Basavapathruni, Aravind

AU - Anderson, Karen S.

AU - Hamilton, Andrew

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Design principles are delineated for non-nucleoside inhibitors for HIV-1 reverse transcriptase (NNRTIs). Simultaneous optimization of binding affinity for wild-type RT, tolerance for viral mutations, and physical properties is pursued. Automated lead generation with the growing program BOMB, Monte Carlo simulations with free-energy perturbation theory for lead optimization, and property analysis with QikProp are featured. An initial 30 μM lead has been optimized rapidly to the 10 nM level.

AB - Design principles are delineated for non-nucleoside inhibitors for HIV-1 reverse transcriptase (NNRTIs). Simultaneous optimization of binding affinity for wild-type RT, tolerance for viral mutations, and physical properties is pursued. Automated lead generation with the growing program BOMB, Monte Carlo simulations with free-energy perturbation theory for lead optimization, and property analysis with QikProp are featured. An initial 30 μM lead has been optimized rapidly to the 10 nM level.

KW - Anti-HIV drugs

KW - Computer-aided drug design

KW - NNRTI

KW - Structure-based drug design

UR - http://www.scopus.com/inward/record.url?scp=29544447433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544447433&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2005.10.038

DO - 10.1016/j.bmcl.2005.10.038

M3 - Article

VL - 16

SP - 663

EP - 667

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 3

ER -